Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 12;6(1):34.
doi: 10.3390/tropicalmed6010034.

Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT)

Affiliations
Review

Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT)

David Nalin. Trop Med Infect Dis. .

Erratum in

Abstract

The original studies demonstrating the efficacy of oral glucose-electrolytes solutions in reducing or eliminating the need for intravenous therapy to correct dehydration caused by acute watery diarrheas (AWD) were focused chiefly on cholera patients. Later research adapted the oral therapy (ORT) methodology for treatment of non-cholera AWDs including for pediatric patients. These adaptations included the 2:1 regimen using 2 parts of the original WHO oral rehydration solution (ORS) formulation followed by 1 part additional plain water, and a "low sodium" packet formulation with similar average electrolyte and glucose concentrations when dissolved in the recommended volume of water. The programmatic desire for a single ORS packet formulation has led to controversy over use of the "low sodium" formulations to treat cholera patients. This is the subject of the current review, with the conclusion that use of the low-sodium ORS to treat cholera patients leads to negative sodium balance, leading to hyponatremia and, in severe cases, particularly in pediatric cholera, to seizures and other complications of sodium depletion. Therefore it is recommended that two separate ORS packet formulations be used, one for cholera therapy and the other for non-cholera pediatric AWD.

Keywords: ORS formulations; cholera; hyponatremia; hyponatremic seizures; hyponatremic sequelae; non-cholera acute watery diarrheas (AWDs); oral rehydration solutions (ORS); sodium balance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Severely dehydrated child in Greentown, Lahore, Pakistan. Note deeply sunken eyes and obtunded appearance. Etiology unknown.
Figure 2
Figure 2
(a) Father pinches abdominal skin as instructed, (b) showing tenting indicating decreased elasticity after withdrawing hand.
Figure 3
Figure 3
Father begins to offer patient oral rehydration solution (ORS) (WHO 90 formulation) to drink.
Figure 4
Figure 4
Patient continues to drink, using hand to keep ORS coming.
Figure 5
Figure 5
Patient now more alert, eyes less sunken at 1 h after starting ORS.
Figure 6
Figure 6
Patient after recovery, with pretreatment appearance on right.
Figure 7
Figure 7
The ultimate goal: another child with acute watery diarrheas (AWD) starting ORS to prevent becoming dehydrated.
Figure 8
Figure 8
Relationship of diarrheal sodium and potassium losses (mEq/L) to stooling rate in 37 cholera patients during a period of maximum diarrhea 12–24 h after admission. At all ages, stool sodium tends to rise and potassium to fall at higher diarrhea rates. The numbers of patients were: 12 (0–4 yrs old), 10 (5–9 yrs), 6 (10–14 yrs), 2 (15–19 yrs), 7 (20 yrs and over). From Lancet, 30 October 1976, p. 957.

Similar articles

Cited by

References

    1. WHO Reduced Osmolarity Oral Rehydration Salts (ORS) Formulation; Department of Child and Adolescent Health and Development. [(accessed on 20 October 2020)]. Available online: https://apps.who.int/iris/handle/10665/67322.
    1. Musekiwa A., Volmink J., Cochrane Infectious Diseases Group Oral Rehydration Salt Solution for Treating Cholera: ≤270 mOs/L solutions vs. ≤310 mOsm/L Solutions. Cochrane Database Syst. Rev. 2011;2011:CD003754. doi: 10.1002/14651858.CD003754.pub3. - DOI - PMC - PubMed
    1. CHOICE Study Group Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics. 2001;107:613–618. doi: 10.1542/peds.107.4.613. - DOI - PubMed
    1. Alam S., Afzal K., Maheshwari M., Shukla I. Controlled trial of hypo-osmolar versus world Health Organization Oral rehydration solution. Indian Pediatrics. 2000;37:952–960. - PubMed
    1. Pulungsih S.P., Punjabi N.H., Rafli K., Rifajati A., Kumala S., Simanjuntak C.H., Yuwono Lesmana M., Subekti D., Sutoto, Fontaine O. Standard WHO_ORS versus reduced-osmolarity ORS in the management of cholera patients. J. Health Popul. Nutr. 2006;24:107–112. - PubMed

LinkOut - more resources